Strs Ohio Lowers Stock Holdings in DaVita Inc. (NYSE:DVA)

Strs Ohio lowered its position in shares of DaVita Inc. (NYSE:DVA) by 4.7% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 14,088 shares of the company’s stock after selling 695 shares during the period. Strs Ohio’s holdings in DaVita were worth $1,475,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also made changes to their positions in the company. State of Michigan Retirement System increased its position in shares of DaVita by 0.6% during the fourth quarter. State of Michigan Retirement System now owns 15,939 shares of the company’s stock worth $1,670,000 after purchasing an additional 100 shares in the last quarter. Treasurer of the State of North Carolina increased its position in DaVita by 0.5% in the 3rd quarter. Treasurer of the State of North Carolina now owns 24,503 shares of the company’s stock valued at $2,316,000 after acquiring an additional 123 shares during the period. Veritable L.P. increased its position in DaVita by 4.6% in the 1st quarter. Veritable L.P. now owns 3,026 shares of the company’s stock valued at $245,000 after acquiring an additional 133 shares during the period. Captrust Financial Advisors increased its position in DaVita by 3.7% in the 1st quarter. Captrust Financial Advisors now owns 3,860 shares of the company’s stock valued at $437,000 after acquiring an additional 139 shares during the period. Finally, Daiwa Securities Group Inc. increased its position in DaVita by 3.2% in the 3rd quarter. Daiwa Securities Group Inc. now owns 4,631 shares of the company’s stock valued at $438,000 after acquiring an additional 144 shares during the period. Institutional investors and hedge funds own 90.12% of the company’s stock.

DaVita Price Performance

Shares of NYSE:DVA opened at $127.82 on Monday. The business’s 50 day simple moving average is $130.68 and its 200-day simple moving average is $109.24. The firm has a market capitalization of $11.21 billion, a price-to-earnings ratio of 17.27, a price-to-earnings-growth ratio of 1.14 and a beta of 1.04. The company has a debt-to-equity ratio of 6.65, a current ratio of 1.19 and a quick ratio of 1.13. DaVita Inc. has a 12 month low of $71.51 and a 12 month high of $141.54.

DaVita (NYSE:DVA) last announced its quarterly earnings results on Tuesday, February 13th. The company reported $1.87 EPS for the quarter, topping the consensus estimate of $1.53 by $0.34. The business had revenue of $3.15 billion for the quarter, compared to analyst estimates of $3.01 billion. DaVita had a return on equity of 64.42% and a net margin of 5.70%. The company’s quarterly revenue was up 7.8% on a year-over-year basis. During the same quarter in the previous year, the company earned $1.11 EPS. As a group, equities analysts forecast that DaVita Inc. will post 9.23 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several equities analysts recently issued reports on the company. UBS Group boosted their price target on DaVita from $113.00 to $134.00 and gave the company a “buy” rating in a research report on Wednesday, February 14th. Barclays assumed coverage on DaVita in a report on Wednesday, March 6th. They issued an “equal weight” rating and a $133.00 price objective on the stock. Truist Financial lifted their price objective on DaVita from $130.00 to $135.00 and gave the company a “hold” rating in a report on Tuesday, February 20th. TheStreet raised DaVita from a “c+” rating to a “b-” rating in a report on Wednesday, February 7th. Finally, StockNews.com lowered DaVita from a “strong-buy” rating to a “buy” rating in a report on Tuesday, April 16th. Two equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the company’s stock. According to data from MarketBeat.com, DaVita presently has a consensus rating of “Moderate Buy” and an average target price of $118.50.

Insider Activity at DaVita

In related news, CEO Javier Rodriguez sold 67,603 shares of the company’s stock in a transaction that occurred on Monday, February 26th. The stock was sold at an average price of $126.11, for a total value of $8,525,414.33. Following the sale, the chief executive officer now owns 488,697 shares of the company’s stock, valued at approximately $61,629,578.67. The transaction was disclosed in a filing with the SEC, which is available through this link. In related news, COO Michael David Staffieri sold 29,488 shares of the company’s stock in a transaction that occurred on Wednesday, February 21st. The stock was sold at an average price of $119.81, for a total value of $3,532,957.28. Following the sale, the chief operating officer now owns 37,687 shares of the company’s stock, valued at approximately $4,515,279.47. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, CEO Javier Rodriguez sold 67,603 shares of the company’s stock in a transaction that occurred on Monday, February 26th. The shares were sold at an average price of $126.11, for a total value of $8,525,414.33. Following the completion of the sale, the chief executive officer now directly owns 488,697 shares in the company, valued at approximately $61,629,578.67. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 134,540 shares of company stock valued at $16,551,071. 1.40% of the stock is owned by corporate insiders.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.